708 related articles for article (PubMed ID: 12606628)
1. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.
Szeto HH; Soong Y; Wu D; Qian X; Zhao GM
J Pharmacol Exp Ther; 2003 May; 305(2):696-702. PubMed ID: 12606628
[TBL] [Abstract][Full Text] [Related]
2. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
3. Profound spinal tolerance after repeated exposure to a highly selective mu-opioid peptide agonist: role of delta-opioid receptors.
Zhao GM; Wu D; Soong Y; Shimoyama M; Berezowska I; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2002 Jul; 302(1):188-96. PubMed ID: 12065716
[TBL] [Abstract][Full Text] [Related]
4. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1] DALDA.
Shimoyama M; Shimoyama N; Zhao GM; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2001 Apr; 297(1):364-71. PubMed ID: 11259564
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
[TBL] [Abstract][Full Text] [Related]
7. [Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine.
Riba P; Ben Y; Nguyen TM; Furst S; Schiller PW; Lee NM
Curr Med Chem; 2002 Jan; 9(1):31-9. PubMed ID: 11860345
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the antinociceptive effects of intrathecal DALDA peptides following bolus intrathecal delivery.
Kokubu S; Eddinger KA; Nguyen TM; Huerta-Esquivel LL; Yamaguchi S; Schiller PW; Yaksh TL
Scand J Pain; 2019 Jan; 19(1):193-206. PubMed ID: 30367811
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, a highly potent and selective mu-opioid peptide.
Neilan CL; Nguyen TM; Schiller PW; Pasternak GW
Eur J Pharmacol; 2001 May; 419(1):15-23. PubMed ID: 11348625
[TBL] [Abstract][Full Text] [Related]
10. Differential analgesic effects of a mu-opioid peptide, [Dmt(1)]DALDA, and morphine.
Shimoyama M; Szeto HH; Schiller PW; Tagaito Y; Tokairin H; Eun Cm; Shimoyama N
Pharmacology; 2009; 83(1):33-7. PubMed ID: 18987489
[TBL] [Abstract][Full Text] [Related]
11. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
12. Structure-constrained endomorphin analogs display differential antinociceptive mechanisms in mice after spinal administration.
Wang Y; Zhou J; Liu X; Zhao L; Wang Z; Zhang X; Wang K; Wang L; Wang R
Peptides; 2017 May; 91():40-48. PubMed ID: 28363796
[TBL] [Abstract][Full Text] [Related]
13. Roles of endogenous opioid peptides in modulation of nocifensive response to formalin.
Wu HE; Hung KC; Mizoguchi H; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2002 Feb; 300(2):647-54. PubMed ID: 11805228
[TBL] [Abstract][Full Text] [Related]
14. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
Sakurada S; Hayashi T; Yuhki M; Orito T; Zadina JE; Kastin AJ; Fujimura T; Murayama K; Sakurada C; Sakurada T; Narita M; Suzuki T; Tan-no K; Tseng LF
Eur J Pharmacol; 2001 Sep; 427(3):203-10. PubMed ID: 11567650
[TBL] [Abstract][Full Text] [Related]
15. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Analgesic Actions of the Chronic Intrathecal Infusion of H-Dmt-D-Arg-Phe-Lys-NH2 in Rat.
Kokubu S; Eddinger KA; Yamaguchi S; Huerta-Esquivel LL; Schiller PW; Yaksh TL
Neuromodulation; 2019 Oct; 22(7):781-789. PubMed ID: 30794333
[TBL] [Abstract][Full Text] [Related]
17. Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2), in mice.
Hiramatsu M; Inoue K; Ambo A; Sasaki Y; Kameyama T
Br J Pharmacol; 2001 Apr; 132(8):1948-56. PubMed ID: 11309268
[TBL] [Abstract][Full Text] [Related]
18. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
[TBL] [Abstract][Full Text] [Related]
19. Tolerance develops in spinal cord, but not in brain with chronic [Dmt1]DALDA treatment.
Ben Y; Smith AP; Schiller PW; Lee NM
Br J Pharmacol; 2004 Dec; 143(8):987-93. PubMed ID: 15557286
[TBL] [Abstract][Full Text] [Related]
20. Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
Wang D; Sun X; Sadee W
J Pharmacol Exp Ther; 2007 May; 321(2):544-52. PubMed ID: 17267582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
